Crinetics stock jumps 99% after Vertex Pharmaceuticals says it’s buying the endocrine treatment specialist for $10 billion.

Zion Market Research has published a new research report titled 'Generative AI in Healthcare Market By Component (Solutions and Services), By Function (Medical Imaging & Diagnostics, Drug Discovery & ...

Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...

Following an independent salary analysis, this landmark certification sets a benchmark for data-driven pay equity and ...

Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...

Novartis has acquired UK biotech Myricx for up to $1.5bn as global drugmakers invest inpromising biotech firms ahead expected ...

Wall Street expects sales to soar as several commercial launches approach.

Island Pharmaceutical’s experimental drug will be used to treat patients in Uganda, as the African nation grapples with the ...

The deal values Crinetics at $85 per share in cash, representing a potential upside of about 100% from the stock’s closing ...

The acquisition would add to Vertex’s pipeline and potentially grow its annual revenue by $5 billion with the addition of ...

A series of biotech acquisitions transpired in under 9 months — totaling more than $3.5 billion. The drugs behind them target ...

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...